Skip to main content
SpringerLink
Log in

Primäre und sekundäre Demenzen

  • Conference paper
Morbus Parkinson

  • 170 Accesses

Zusammenfassung

Die Konnotation der Beziechnung „primäre“ Demenz umfasst die Eigenschaften „häufig, gesetzäßig, unweigerlich, genuin, kryptogen,...“.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Alexander EL (1993) Neurologic disease in Sjogren’s syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscles, a clinical review and update of immunopathogenesis. Rheum Dis Clin North Am 19: 869–908

    PubMed  CAS  Google Scholar 

  2. American Academy of Neurology AIDS Task Force (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 41: 778–785

    Article  Google Scholar 

  3. Bell IR, Edman JS, Marby DW et al. (1990) Vitamin B12 and folate status in acute geropsychiatric inpatients: affective and cognitive characteristics of a vitamin nondeficient population. Biol Psychiatry 27: 125–137

    Article  PubMed  CAS  Google Scholar 

  4. Bell IR, Edman JS, Miller Jet al. (1990) Relationship of normal serum vitamin B12 to cognitive test performance in subtypes of geriatric major depression. J Geriatr Psychiatry Neurol 3: 98–105

    Article  PubMed  CAS  Google Scholar 

  5. Brashear A, Unverzagt FW, Farber MO et al. (1996) Ethylene oxide neurotoxicity: a cluster of 12 nurses with peripheral and central nervous system toxicity. Neurology 46: 992–998

    Article  PubMed  CAS  Google Scholar 

  6. Brewer CJ, Fink JK, Hedera P (1999) Diagnosis and Treatment of Wilson’s Disease. Seminars in Neurology 19: 261–270

    Article  PubMed  CAS  Google Scholar 

  7. Carmel R (1997) Cobalamin, the stomach, and ageing. Am J Clin Nutr 66: 750–759

    PubMed  CAS  Google Scholar 

  8. Clifford DB (2002) AIDS dementia. Med Clin North Am 86: 537–550

    Article  PubMed  Google Scholar 

  9. Crystal HA, Dickson D, Davis P, Masur D, Grober E, Lipton RB (2001) The relative frequency of “dementia of unknown etiology” increases with age and is nearly 50% in nonagenarians. Arch Neurol 58: 1498–1499

    Article  Google Scholar 

  10. Cummings JL, Benson DF (1992) Dementia: A clinical approach., 2ndedn. Butterworth, Stoneham, MA

    Google Scholar 

  11. Denburg SD, Denburg JA, Carbotte RM et al. (1993) Cognitive deficits in systemic lupus erythematosus. Theum Dis Clin North Am 19: 815–831

    CAS  Google Scholar 

  12. Devinsky 0 (1995) Cognitive and behavioural effects of antiepileptic drugs. Epilepsia 36 (Suppl 2): S46–65

    Article  Google Scholar 

  13. Ellis WG, Sobel RA, Nielsen SL (1982) Leukoencephalopathy in patients treated with amphotericin B methyl ester. J Infect Dis 146: 125–137

    Article  PubMed  CAS  Google Scholar 

  14. Fallon BA, Nields JA (1994) Lyme disease: a neuropsychiatric illness. Am J Psychiatry 151: 1571–1583

    PubMed  CAS  Google Scholar 

  15. Filley CM, Heaton RK, Rosenberg NL (1990) White matter dementia in chronic toluene abuse. Neurology 40: 532–534

    Article  PubMed  CAS  Google Scholar 

  16. Finlay BL, Darlington RB (1995) Linked regularities in the development and evolution of mammalian brains. Science 268: 1578–1584

    Article  PubMed  CAS  Google Scholar 

  17. Fioravanti M, Ferrario E, Massaia M (1997) Low folate levels in the cognitive decline of eldelry patients and the efficacy of folate as a treatment for improving memory deficits. Arch Gerontol Geriatr 26: 1–13

    Article  CAS  Google Scholar 

  18. Hankey GJ (2002) Is homocysteine a causal and treatable risk factor for vascular disease of the brain (cognitive impairment and stroke)? Ann Neurol 51: 279–281

    Article  PubMed  Google Scholar 

  19. Hanley JG (1998) Evaluation of patients with CNS involvement in SLE. Baillieres Clin Rheum 12: 415–431

    Article  Google Scholar 

  20. Hwang TL, Yung WK, Estey EH et al. (1985) Central nervous system toxicity with high-dose Ara-C. Neurology 35: 1475–1479

    Article  PubMed  CAS  Google Scholar 

  21. Janssen RS, Nwanyanwu OC, Selik RM et al. (1992) Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 42: 1472–1476

    Article  PubMed  CAS  Google Scholar 

  22. Martin DC, Francis J, Protech J, Huff JF (1992) Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc 40: 168–172

    PubMed  CAS  Google Scholar 

  23. Morley JE (1997) Anorexia of ageing: physiologic and pathologic. Am J Clin Nutr 66: 760–773

    PubMed  CAS  Google Scholar 

  24. Moutsopoulos HM, Sarmas JH, Talal N (1993) Is central nervous system involvement a systemic manifestation of primary Sjogren’s syndrome? Rheum Dis Clin North Am 19: 909–912

    PubMed  CAS  Google Scholar 

  25. MRC CFAS Study (2001) Pathological correlates of late-onset dementia in multicentre, community-based population in England and Wales. Lancet 357: 169–175

    Google Scholar 

  26. Papazian 0, Canziales E, Alfonso I et al. (1995) Reversible dementia and apparent brain atrophy during valproate therapy. Ann Neurol 38: 687–691

    Article  PubMed  CAS  Google Scholar 

  27. Parsons OA (1998) Neurocognitive deficits in alcoholics and social drinkers: a continuum? Alcohol Clin Exp Res 22: 954–961

    PubMed  CAS  Google Scholar 

  28. Pavol MA, MeyersCA, Rexer JL et al. (1995) Pettern of neurobehavioral deficits associated with interferon alfa. Neurology 45: 947–950

    Article  PubMed  CAS  Google Scholar 

  29. Peyser JM, Rao SM, LaRocca NG, Kaplan E (1990) Guidelines for neuropsychological research in multiple sclerosis. Arch Neurol 47: 94–97

    Article  PubMed  CAS  Google Scholar 

  30. Power C, Johnson RT (1995) HIV-1 associated dementia: clinical features and pathogenesis. Can J Neurol Sci 22: 92–100

    PubMed  CAS  Google Scholar 

  31. Rao SM (1996) White matter disease and dementia. Brain Cogn 31: 250–268

    Article  PubMed  CAS  Google Scholar 

  32. Rao SM, Leo GJ, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis. 1. Frequency patterns and prediction. Neurology 41: 685–691

    Article  PubMed  CAS  Google Scholar 

  33. Rourke SB, Grant I (1999) The interactive effects of age and length of abstinence on the recovery of neuropsychological functioning in chronic male alcoholics: a 2-year follow-up study. J Int Neuropsychol Soc 5: 234–246

    Article  PubMed  CAS  Google Scholar 

  34. Spencer MD, Knight RS, Will RG (2002) First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case review of early psychiatric and neurological features. BMJ 324: 1479–1482

    Article  PubMed  Google Scholar 

  35. Swirsky-Sachetti T, Mitchell DR, Seward Jet al. (1992) Neuropsychological and structural brain lesions in multiple sclerosis: a regional analysis. Neurology 42: 1291–1295

    Article  Google Scholar 

  36. Victor M (1994) Alcoholic Dementia. Can J Neurol Sci: 88–99

    Google Scholar 

  37. Waniek C, Prohovnik I, Kaufman MA et al. (1995) Rapidly progressive frontal-type dementia associated with Lyme disease. J Neuropsychiatry Clin Neurosci 7: 345–347

    PubMed  CAS  Google Scholar 

  38. West SG (1994) Neuropsychiatric lupus. Rheum Dis Clin North Am 20: 367–370

    Google Scholar 

  39. Yamamori C, Oshino H, Inagaki T et al. (1994) Neuro-Behget disease with demyelination and gliosis of the frontal white matter. Clinc Neuropathol 13: 208–215

    CAS  Google Scholar 

Download references

Authors
  1. N. T. Lautenschlager
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Förstl
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurologische Klinik der Ruhr-Universität Bochum St. Josef-Hospital, Gudrunstraße 56, 44791, Bochum, Germany

    Horst Przuntek  & Thomas Müller  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Lautenschlager, N.T., Förstl, H. (2003). Primäre und sekundäre Demenzen. In: Przuntek, H., Müller, T. (eds) Morbus Parkinson. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57362-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57362-0_2

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-7985-1422-5

  • Online ISBN: 978-3-642-57362-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation